CLINICAL_TRIALS
trial_result
· 2020-01-18
Clinical Trial Update: A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung [Phase 2]
Summary
Phase 2 placebo-controlled trial of saracatinib in patients with recurrent osteosarcoma localized to the lung was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Osteosarcoma | Phase 2 | Status: TERMINATED | Results posted: 2020-01-18